Viewing nowEzetimibe 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

MFDS item code 201400383 · Approved 2014.01.28 · Insurance code 644704200
Improvement of dyslipidemia, inhibition of atherosclerosis progression, reduction of cardiovascular disease risk
This medication is primarily used as an adjunct to diet and exercise when primary hypercholesterolemia, mixed dyslipidemia, or familial hypercholesterolemia cannot be controlled. It particularly lowers LDL cholesterol levels, delaying the progression of atherosclerosis, and is also used in certain pediatric patients aged 10 years and older. Furthermore, it helps reduce the risk of cardiovascular complications such as stroke, myocardial infarction, and arterial revascularization in patients at high risk for cardiovascular disease. Thus, this drug is used for cholesterol control and cardiovascular disease prevention.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended therapeutic goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, patients who are allergic to this drug, have severely impaired liver function, muscle disorders, severe kidney disorders, or are pregnant or nursing should not take it. Additionally, since this drug may affect liver function, patients with a history of liver disease or those who consume alcohol heavily should use it cautiously. It is advisable to have regular liver function tests before and during the use of this medication. Symptoms such as muscle pain or weakness may occur, and in rare cases, serious muscle damage known as rhabdomyolysis may develop. If these symptoms occur, notify a doctor immediately, and the medication may need to be stopped if necessary. This drug may interact with other medications, so caution should be exercised, especially when taken with certain antiviral agents, immunosuppressants, antibiotics, and fibrate drugs. Increased risk of muscle damage may occur with combinations, so consult a doctor. Women of childbearing potential should use appropriate contraceptive methods to avoid pregnancy, and it is safest not to take this medication during pregnancy. Nursing mothers are also advised to avoid this medication. In the event of an overdose, there is no specific antidote, and treatment should be symptomatic, while checking liver function and muscle-related tests to monitor the condition. This drug has rarely been reported to cause interstitial lung disease, liver damage, increased blood glucose levels, and memory loss, so if any abnormal symptoms occur, the healthcare provider should be notified immediately. Caution is needed as dizziness may occur when driving or operating machinery.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory impairment, forgetfulness, amnesic syndrome, memory disorders, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, joint pain, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a well-sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the effectiveness of the medication.
Yellow round film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.